Início/Ações/DERM

DERM

USD

Journey Medical Corporation Common Stock

$9.000+0.590 (7.015%)

Preço em tempo real

Healthcare

Drug Manufacturers - Specialty & Generic

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$8.410

Máximo

$9.010

Mínimo

$8.260

Volume

0.22M

Fundamentos da empresa

Capitalização de mercado

236.8M

Setor

Drug Manufacturers - Specialty & Generic

País

United States

Estatísticas de negociação

Volume médio

0.16M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $3.535Atual $9.000Máximo $9.01

Notícias relacionadas

24/10/2025 · 12:30

GlobeNewswire

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea

Ver mais

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

8/10/2025 · 12:30

GlobeNewswire

Journey Medical Corporation to Participate in October 2025 Investor Conferences

SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing

Ver mais